Is Infigratinib effective against L585 mutation in lung cancer?

Infigratinib/Infigratinib (Infigratinib) is mainly studied and used to treat a rare type of cancer, namely gallbladder. Cholangiocarcinoma (Cholangiocarcinoma ), especially those with specific genetic alterations (such as FGFR2 gene fusions or rearrangements). However, lung cancer and cholangiocarcinoma are two different cancer types with significantly different pathogenesis, genetic mutations, and treatments.

Lung cancer is usually divided into two main types: non-small cell lung cancer (Non-Small Cell Lung Cancer, NSCLC) and small cell lung cancer (Small Cell Lung Cancer, SCLC). ForNSCLC, a variety of genetic mutations have been discovered, some of which can serve as markers for targeted therapy. Some approved targeted drugs, such as gefitinib (Gefitinib), erbetinib (Erlotinib), pemetrexed (Pemetrexed), etc., have been used to treat specific NSCLC subtypes. However, for L585 mutations in lung cancer, infitinib/infigratinib is not the preferred targeted therapy.

Clinical experimental data on the therapeutic effect of infitinib/infigratinib in lung cancer L585 mutation is very limited, so it is difficult to make a detailed assessment. Research and clinical trials often evaluate the efficacy of different drugs in tumors with different mutations, but currently Infigratinib is mainly used to treat cholangiocarcinoma.

To be sureInfitinib/InfigratinibWhether it is effective against lung cancerL585 mutation requires further research and clinical trials. The trials will evaluate the drug's safety and effectiveness, as well as determine which specific mutant lung cancers may benefit from infigratinib/infigratinib treatment. In addition, scientists may study different targeted drugs to find ones more suitable for treating specific mutations in lung cancer.

Infigratinib/Infigratinib It is not currently available in the country, and it is unlikely to be included in medical insurance. Patients cannot purchase it domestically and can only purchase it through overseas channels. Foreign Infigratinib/Infigratinib only has original drugs, only American original drugs, and the price is as high as about 200,000.